Materiality (Key Issues) and
Our non-financial goals
SNBL has identified a total of seven materiality issues, three for "solving social issues through business" and four for "strengthening our management base to meet social demands," in order to sustainably increase corporate value. Addressing these materialities will also contribute to the achievement of the SDGs and the realization of a sustainable society.
Solving Social Issues Through Business
1. Support for Drug Discovery and Medical Technology Improvement (Enhancing Access to Pharmaceuticals)
Submateriality | KPIs | the goal |
---|---|---|
Creating Time Value in Non-Clinical Trials |
|
|
Towards Becoming a Top CRO Improving scientific capabilities |
|
|
For Unmet Medical Needs contribution |
|
|
Support for Bioventures |
|
|
2. Providing a Healthy Life (Well-being Living)
Submateriality | KPIs | the goal |
---|---|---|
Achieving Well-Being |
|
|
Enhancing Hospitality Mindset |
|
|
3. Preservation of a Beautiful Global Environment
Submateriality | KPIs | the goal |
---|---|---|
Achieving Carbon Neutrality |
|
|
Transition to a Circular Economy |
|
|
Transition to Nature Positive |
|
|
Strengthening Management Foundations to Meet Social Demands
4. Creating an Organization Where Work is Enjoyable
Submateriality | KPIs | the goal |
---|---|---|
Diversity, Equity & Promoting inclusion |
|
|
Promoting human capital management |
|
|
Promoting health and productivity management |
|
|
Mutual growth of employees and the company |
|
|
5. Business Evolution Through DX/RPA Promotion
Submateriality | KPIs | the goal |
---|---|---|
Digitization of test data |
|
|
6. Improvement of Stakeholder Engagement
Submateriality | KPIs | the goal |
---|---|---|
Maximizing customer benefits |
|
|
Sharing growth with business partners |
|
|
Improving shareholder value |
|
|
7. Building governance to realize the corporate philosophy
Submateriality | KPIs | the goal |
---|---|---|
Improving the functioning of the Board of Directors |
|
|
Promoting fair business activities |
|
|
Compliance |
|
|
Main Opportunities and Risks for Each Materiality
Materiality | Main Opportunities | Main risks |
---|---|---|
Support for the advancement of drug discovery and medical technology Improving access to pharmaceuticals |
|
|
Providing a healthy life A well-being lifestyle |
|
|
Preserving the beautiful global environment |
|
|
Creating an organization where the joy of working can be practiced |
|
|
Evolution of Business through DX/RPA Promotion |
|
|
Improvement of stakeholder engagement |
|
|
Realizing our corporate philosophy Building governance |
|
|
Materiality identification process
1. Understanding and consolidating social issues and social demands
Based on various guidelines (SDGs, GRI guidelines, etc.), ESG rating agency indicators, and Japanese government guidelines, identify 'social issues' to be solved through business and 'social demands' for strengthening the management foundation, organize similar items, and consolidate them into 30 items considering their relevance to our company.
2. Identification of important stakeholders
Identify our company's important stakeholders in collaboration with each business division and organize the expectations and demands from stakeholders.
3. Extraction of high-priority issues and demands
Based on our company's desired future state, consider the risks and opportunities for our company regarding the 30 'social issues' and 'social demands', and extract high-priority issues and demands as materiality candidates.
4. Identification of materiality and opportunities, risks, and KPIs
Organize the opportunities, risks, and desired state for the extracted materiality candidates, and identify 7 important items as materiality.